Pickup JC. Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med 2012; 366:Pickup JC. Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med 2012;366:1616-24.Pickup JC. Insulin-pump therapy for type 1 diabetes mellitus. NEJM 2012; 366: 1616-1624....
We present the case of a 29.5-year-old girl with Down's syndrome, type 1 diabetes mellitus (DMT1), autoimmune thyroiditis and celiac disease starting on insulin pump therapy. After 22-month follow-up hemoglobin A1c dropped from 9% to 6.8%, even with a lower insulin requirement and no cha...
Despite >30 years of experience with, and marked improvements in, insulin pumps for treatment of type 1 diabetes mellitus, use of these devices in paediatrics has remained controversial. However, a recent report provides convincing new evidence of the long-term benefits of pump therapy in children...
There is robust evidencesupporting the use of insulin-pump therapy to improve the quality of life for people with type 1 diabetes, and we find the omission of this indication unfortunate. Not only would his limited recommendations, if followed, remove this invaluable therapeutic option for many ...
, a rapid-acting inhaled insulin, is FDA-approved for use before meals for both type 1 and type 2 diabetes. The drug peaks in your blood in about 15-20 minutes and it clears your body in 2-3 hours. It must be used along with long-acting insulin in people with type 1 diabetes....
Type-1-diabetes-mellitus, treatmentDiscusses the benefits of insulin pump therapy for pediatric patients with type 1 diabetic mellitus. Effect of the therapy on hemoglobin levels of the patients; Decline in the frequency of severe hypoglycemia episodes; Comparison between the quality of life scores ...
The current goals for the therapy of children and adolescents with type 1 diabetes mellitus are to achieve as near- normal glycaemia with a minimum risk of severe hypoglycemia, to limit excessive weight gain while achieving adequate growth, to improve quality of life for both the patients and ...
The level of glycaemic control necessary to achieve optimal outcomes in subjects with type 1 diabetes mellitus typically requires intensified insulin therapy using multiple daily injections or continuous subcutaneous insulin infusion (CSII). For CSII, the insulins of choice are the rapid-acting insulin...
The evidence base for the efficacy of insulin pump therapy in type 2 diabetes mellitus (T2DM) has been inconsistent to date. However, a recent large-scale randomized controlled trial comparing pump treatment with multiple daily insulin injections in patients with poorly controlled T2DM has shown subs...
Sensor-augmented pump therapy (SAPT) leads to lower glycated hemoglobin levels than multiple daily injections of insulin (MDI) in patients with type 1 diabetes. Patient time and costs associated with SAPT are not known.We compared time spent on diabetes-related care, changes in time, and assoc...